Recovery of Viable Bacteria from Probiotic Products that Target Oral Health.

about

Probiotics in dietary guidelines and clinical recommendations outside the European Union The ecological community of commensal, symbiotic, and pathogenic gastrointestinal microorganisms - an appraisal

P2860

Q26824061-02A66EAE-7E69-4FAA-9ABA-C3F54FFA8DDC Q33662740-010A27A3-D485-4416-8D2A-1F83463F1ED4

P2860

Recovery of Viable Bacteria from Probiotic Products that Target Oral Health.

Item

http://www.wikidata.org/entity/Q42584265

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Recovery of Viable Bacteria from Probiotic Products that Target Oral Health.

@en

Recovery of Viable Bacteria from Probiotic Products that Target Oral Health.

@nl

type

Item

label

Recovery of Viable Bacteria from Probiotic Products that Target Oral Health.

@en

Recovery of Viable Bacteria from Probiotic Products that Target Oral Health.

@nl

prefLabel

Recovery of Viable Bacteria from Probiotic Products that Target Oral Health.

@en

Recovery of Viable Bacteria from Probiotic Products that Target Oral Health.

@nl

P1476

Recovery of Viable Bacteria from Probiotic Products that Target Oral Health.

@en

P2093

Eric T Popp

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Banas

http://www.w3.org/2001/XMLSchema#string

P2860

Probiotics and oral health

Recent advances in the role of probiotics in human inflammation and gut health.

Role of friendly bacteria in oral health - a short review.

Prebiotics, probiotics and digestive health.

Probiotics in luminal gastroenterology: the current state of play.

Genome sequence of the bacteriocin-producing oral probiotic Streptococcus salivarius strain M18.

Bacillus coagulans GBI-30, 6086 limits the recurrence of Clostridium difficile-Induced colitis following vancomycin withdrawal in mice.

Probiotic metabolites from Bacillus coagulans GanedenBC30™ support maturation of antigen-presenting cells in vitro.

Preliminary pediatric clinical evaluation of the oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes and recurrent acute otitis media.

Competitive properties of lactate dehydrogenase mutants of the oral bacterium Streptococcus mutans in the rat.

P2888

s12602-013-9142-2

P304

227-231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12602-013-9142-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256470691

http://www.w3.org/2001/XMLSchema#string

P698

24015157

http://www.w3.org/2001/XMLSchema#string

P921

probiotics

P932

3762494

http://www.w3.org/2001/XMLSchema#string

Recovery of Viable Bacteria from Probiotic Products that Target Oral Health.

about

P2860

P2860

Recovery of Viable Bacteria from Probiotic Products that Target Oral Health.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932